Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| phenoxodiol prostate |
|
Marshall Edwards Inc. - Phenoxodiol "Promising data on phenoxodiol in prostate cancer piqued our interest," said Wm. Kevin Kelly, DO, principle investigator for the trial, Associate Professor Yale Cancer Center Sponsors Study of Phenoxodiol for Prostate Yale researchers have begun recruiting 60 men for a clinical trial investigating an experimental new drug, oral phenoxodiol, as a potential first line Marshall Edwards Inc. - Phenoxodiol CHICAGO - September 14, 2006 -- A new study demonstrates that the investigational drug, phenoxodiol, may be effective in the treatment of prostate cancer Early Study Provides Evidence That Investigational Drug A new study demonstrates that the investigational drug, phenoxodiol, may be effective in the treatment of prostate cancer through its ability to target a Phenoxodiol Targets Prostate Cancer Protein-- May Lead to New Phenoxodiol Targets Prostate Cancer Protein-- May Lead to New Treatment. National Prostate Cancer Coalition: Phenoxodiol Reverses Phenoxodiol is being developed as a chemo-sensitizer for standard chemotherapy agents such as taxanes and platinums in ovarian cancer, and has been granted Healthcare Sales & Marketing Network: Medical Device and FDA Grants Fast Track Designation for Phenoxodiol in Oral Dosage Form for Prostate Cancer HSMN NewsFeed, 26 Jan 2005: Biopharmaceuticals, FDA, Oncology Marshall Edwards Phenoxodiol prostate cancer MSH Marshall Edwards Marshall Edwards Phenoxodiol prostate cancer. Advanced ovarian cancer- phenoxodiol? (prostate cancer) - Mombu Advanced ovarian cancer- phenoxodiol? (prostate cancer) MEDICINE. phenoxodiol Professor Kelly said that the next stage of development of phenoxodiol for prostate cancer would be to use it in patients who have failed to respond to both Phenoxodiol trials: focus on ovarian not prostate cancer | psa Phenoxodiolâ™s fast track status at FDA generates a lot on interest among men with advanced prostate cancer. But despite evidence that Phenoxodiol delays |
| phenoxodiol prostate |
|
impact program prostate cancer homeopathic remedy enlarged prostate late stage prostate cancer protocol prostate cancer life expectancy |